135 related articles for article (PubMed ID: 12150158)
1. Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course.
Chang CC; Cleveland RP
Blood; 2002 Aug; 100(3):1106. PubMed ID: 12150158
[No Abstract] [Full Text] [Related]
2. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.
Ishibe N; Albitar M; Jilani IB; Goldin LR; Marti GE; Caporaso NE
Blood; 2002 Aug; 100(3):1100-1. PubMed ID: 12150154
[No Abstract] [Full Text] [Related]
4. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
Morabito F; Mangiola M; Oliva B; Stelitano C; Callea V; Deaglio S; Iacopino P; Brugiatelli M; Malavasi F
Leuk Res; 2001 Nov; 25(11):927-32. PubMed ID: 11597727
[TBL] [Abstract][Full Text] [Related]
5. CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.
Sun L; Adebanjo OA; Moonga BS; Corisdeo S; Anandatheerthavarada HK; Biswas G; Arakawa T; Hakeda Y; Koval A; Sodam B; Bevis PJ; Moser AJ; Lai FA; Epstein S; Troen BR; Kumegawa M; Zaidi M
J Cell Biol; 1999 Sep; 146(5):1161-72. PubMed ID: 10477767
[TBL] [Abstract][Full Text] [Related]
6. The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer.
Shubinsky G; Schlesinger M
Immunity; 1997 Sep; 7(3):315-24. PubMed ID: 9324352
[No Abstract] [Full Text] [Related]
7. Purification and characterization of ADP-ribosyl cyclase from Euglena gracilis.
Masuda W; Takenaka S; Tsuyama S; Inui H; Miyatake K; Nakano Y
J Biochem; 1999 Mar; 125(3):449-53. PubMed ID: 10050031
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of CD38/ADP-ribosyl cyclase from rat lung.
Khoo KM; Chang CF
Biochem Mol Biol Int; 1998 Apr; 44(4):841-50. PubMed ID: 9584998
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of cyclic ADP-ribose: a new role for NAD+ glycohydrolases.
Ziegler M; Jorcke D; Schweiger M
Rev Physiol Biochem Pharmacol; 1997; 131():89-126. PubMed ID: 9204690
[No Abstract] [Full Text] [Related]
10. CD38: an 'orphan' protein that may be finding a home?
Felgar RE
Leuk Res; 2000 Feb; 24(2):161-2. PubMed ID: 10654452
[No Abstract] [Full Text] [Related]
11. All-trans-retinoic acid up-regulates CD38 but not c-Kit antigens on human marrow CD34+ cells without recruitment into cell cycle.
Herault O; Domenech J; Degenne M; Bremond JL; Sensebe L; Bernard MC; Binet C; Colombat P
Br J Haematol; 1998 Nov; 103(2):343-50. PubMed ID: 9827903
[TBL] [Abstract][Full Text] [Related]
12. Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157).
Sato A; Yamamoto S; Ishihara K; Hirano T; Jingami H
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):491-6. PubMed ID: 9895292
[TBL] [Abstract][Full Text] [Related]
13. Human CD38 is an authentic NAD(P)+ glycohydrolase.
Berthelier V; Tixier JM; Muller-Steffner H; Schuber F; Deterre P
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1383-90. PubMed ID: 9494110
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin V genes and CD38 expression in CLL.
Hamblin TJ; Orchard JA; Gardiner A; Oscier DG; Davis Z; Stevenson FK
Blood; 2000 Apr; 95(7):2455-7. PubMed ID: 10787241
[No Abstract] [Full Text] [Related]
15. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia.
Thunberg U; Johnson A; Roos G; Thörn I; Tobin G; Sällström J; Sundström C; Rosenquist R
Blood; 2001 Mar; 97(6):1892-4. PubMed ID: 11263438
[No Abstract] [Full Text] [Related]
16. Stimulation of ADP-ribosyl cyclase activity of the cell surface antigen CD38 by zinc ions resulting from inhibition of its NAD+ glycohydrolase activity.
Kukimoto I; Hoshino S; Kontani K; Inageda K; Nishina H; Takahashi K; Katada T
Eur J Biochem; 1996 Jul; 239(1):177-82. PubMed ID: 8706705
[TBL] [Abstract][Full Text] [Related]
17. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
18. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.
Donís-Hernández FR; Parkhouse RM; Santos-Argumedo L
Eur J Immunol; 2001 Apr; 31(4):1261-7. PubMed ID: 11298353
[TBL] [Abstract][Full Text] [Related]
19. Functional role of glycosylation on the recombinant CD38/ADP-ribosyl cyclase in CHO cells.
Chidambaram N; Chang CF
Int J Biochem Cell Biol; 1998 Sep; 30(9):1011-8. PubMed ID: 9785464
[TBL] [Abstract][Full Text] [Related]
20. Estrogen increases CD38 gene expression and leads to differential regulation of adenosine diphosphate (ADP)-ribosyl cyclase and cyclic ADP-ribose hydrolase activities in rat myometrium.
Dogan S; White TA; Deshpande DA; Murtaugh MP; Walseth TF; Kannan MS
Biol Reprod; 2002 Mar; 66(3):596-602. PubMed ID: 11870063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
